← The Wire
CRMDNasdaq
CorMedix Inc.
Pharmaceutical Preparations · DE · CIK 1410098
CorMedix develops and commercializes therapeutic products for life-threatening diseases, including DefenCath for hemodialysis and infectious disease treatments
$686M
Market cap
$7.64
Last close
-2.7%
1D
-13.4%
5D
1.3M
Volume
Price · last 39 sessions-3.3%
May 4L $7.50 · H $8.96Jun 29
395
Total filings
Jun 24, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 24, 20268-KReg FD DisclosureJun 8, 202610-Q10-QMay 14, 20268-KResults of OperationsMay 14, 2026DEFA14ADEFINITIVE ADDITIONAL MATERIALSApr 29, 2026DEF 14APROXY STATEMENTApr 29, 20268-KReg FD DisclosureApr 27, 20268-KReg FD DisclosureMar 6, 202610-KANNUAL REPORTMar 5, 20268-KResults of OperationsMar 5, 20268-KExecutive Change · Results of OperationsJan 8, 202610-QQUARTERLY REPORTNov 12, 20258-KResults of OperationsNov 12, 2025DEF 14APROXY STATEMENTOct 24, 20258-KResults of OperationsOct 20, 20258-K/ACompany UpdateSep 30, 20258-KExecutive Change · Material AgreementSep 2, 20258-KMaterial Agreement · Equity IssuanceAug 12, 202510-QQUARTERLY REPORTAug 7, 20258-KMaterial Agreement · Results of OperationsAug 7, 20258-KCompany UpdateJun 30, 2025424B5PROSPECTUS SUPPLEMENTJun 30, 2025424B5PROSPECTUS SUPPLEMENTJun 26, 20258-KShareholder VoteJun 25, 20258-KReg FD DisclosureJun 23, 202510-QQUARTERLY REPORTMay 6, 20258-KResults of OperationsMay 6, 2025DEFA14ADEFINITIVE ADDITIONAL MATERIALSApr 28, 2025DEF 14APROXY STATEMENTApr 28, 20258-KAuditor ChangeApr 22, 20258-KResults of OperationsApr 8, 202510-KANNUAL REPORTMar 25, 20258-KResults of OperationsMar 25, 20258-KResults of OperationsJan 7, 20258-KExecutive Change · Shareholder VoteNov 25, 202410-QQUARTERLY REPORTOct 30, 20248-KResults of OperationsOct 30, 2024DEF 14APROXY STATEMENTOct 8, 202410-QQUARTERLY REPORTAug 14, 20248-KResults of OperationsAug 14, 202410-QQUARTERLY REPORTMay 9, 20248-KResults of OperationsMay 9, 202410-KANNUAL REPORTMar 12, 20248-KResults of OperationsMar 12, 2024SC 13GSCHEDULE 13GFeb 13, 20248-KCompany UpdateJan 30, 2024SC 13GSC 13GJan 29, 20248-KExecutive ChangeDec 15, 20238-KCompany UpdateNov 16, 202310-QQUARTERLY REPORTNov 14, 20238-KResults of OperationsNov 14, 20238-KShareholder VoteOct 30, 2023DEFA14ADEFINITIVE ADDITIONAL MATERIALSSep 13, 2023DEF 14APROXY STATEMENTSep 13, 20238-KExecutive ChangeAug 17, 202310-QQUARTERLY REPORTAug 8, 20238-KResults of OperationsAug 8, 20238-KCompany UpdateJun 30, 2023424B5PROSPECTUS SUPPLEMENTJun 30, 2023424B5PRELIMINARY PROSPECTUS SUPPLEMENTJun 28, 20238-KCompany UpdateJun 21, 20238-KCompany UpdateMay 16, 202310-QQUARTERLY REPORTMay 15, 20238-KResults of OperationsMay 15, 20238-KCompany UpdateApr 26, 20238-KExecutive Change · Company UpdateApr 17, 202310-KANNUAL REPORTMar 30, 20238-KResults of OperationsMar 30, 20238-KCompany UpdateMar 3, 202310-QQUARTERLY REPORTNov 10, 20228-KResults of OperationsNov 10, 20228-KAuditor ChangeOct 21, 20228-KShareholder VoteOct 17, 2022DEFA14ADEFINITIVE ADDITIONAL MATERIALSAug 30, 2022DEF 14ADEFINITIVE PROXY STATEMENTAug 30, 202210-QQUARTERLY REPORTAug 11, 20228-KResults of OperationsAug 11, 20228-KCompany UpdateAug 9, 2022SC 13GSC 13GJul 8, 202210-QQUARTERLY REPORTMay 12, 2022
Insider Activity
In the 90 days to Jan 21, 2026: 1 insider bought $276K · 4 sold $2.6M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 21, 2026 | Dillione JanetDirector | Sell | 10,000 | $6.88 | $69K |
| Dec 30, 2025 | Dunton Alan WDirector | Sell | 20,000 | $13.00 | $260K |
| Dec 18, 2025 | Todisco JosephChief Executive Officer | Sell | 30,000 | $12.00 | $360K |
| Dec 9, 2025 | Lefkowitz Steven WDirector | Sell | 40,000 | $11.88 | $475K |
| Dec 9, 2025 | Dillione JanetDirector | Sell | 34,000 | $12.00 | $408K |
| Dec 2, 2025 | Dillione JanetDirector | Sell | 46,657 | $10.00 | $467K |
| Nov 24, 2025 | Dillione JanetDirector | Sell | 26,343 | $9.93 | $262K |
| Nov 14, 2025 | Dillione JanetDirector | Sell | 30,000 | $11.42 | $343K |
| Oct 23, 2025 | Kaplan MyronDirector | Buy | 25,000 | $11.02 | $276K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance